Healthpeak Properties Raises 2026 Earnings Guidance Following Completion of the Janus Living IPO, Accretive Capital Allocation, and Strong First Quarter 2026 Results
Healthpeak Properties raised its 2026 diluted EPS guidance to $0.46-$0.50, up from the prior range of $0.34-$0.38, driven by the completion of the accretive Janus Living IPO and strong Q1 results. The company repurchased 5.9 million shares for approximately $100 million and sold an 80% interest in a six-property outpatient portfolio to Blackstone affiliates for $170 million in gross proceeds.
Key figures
- Eps
- 0.28
- Revenue
- 752952000
- Guidance
- 2026 Diluted EPS $0.46-$0.50 (raised from $0.34-$0.38); FFO as Adjusted $1.71-$1.75 (raised from $1.70-$1.74); Nareit FFO $1.68-$1.72 (prior $1.70-$1.74)
- Revenue Yoy
- 35%
- Nareit ffo
- 0.42
- Ffo as adjusted
- 0.45
- Janus market cap
- 6.9 billion
- Janus ipo proceeds
- 880000000
- Ss noi growth total
- 0.0%
- Net debt to ebitda re
- 5.4x
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.